Skip to main content
Clinical Trials/TCTR20230918002
TCTR20230918002
Recruiting
Not Applicable

Prevalence and factors associated with post COVID-19 syndrome

School of Integrative Medicine0 sites166 target enrollmentSeptember 18, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Post COVID-19 syndrome
Sponsor
School of Integrative Medicine
Enrollment
166
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 18, 2023
End Date
December 29, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
School of Integrative Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged between 18 and 60 years.
  • 2\. Experiencing at least one of the following post\-COVID\-19 symptoms for a duration of at least four weeks after the COVID\-19 infection: fatigue, dyspnea, musculoskeletal pain, cough, headache, palpitation, decreased exercise capacity, loss of appetite, nausea, etc.
  • 3\. Have received a diagnosis of COVID\-19 infection through RT\-PCR or ATK testing.
  • 4\. Capable of effective communication and able to follow instructions.

Exclusion Criteria

  • 1\. History of cardiovascular diseases.
  • 2\. History of syncope or autonomic abnormalities before COVID\-19 infection.
  • 3\. Use of drugs affecting the autonomic nervous system, e.g., beta\-blockers, etc.
  • 4\. Alcoholism or current smoking.
  • 5\. Pregnancy.
  • 6\. History of cleft lip and cleft palate.
  • 7\. Body temperature exceeding 37\.5 degrees Celsius.
  • 8\. Unstable cardiovascular function: heart rate \> 100 bpm, blood pressure \< 90/60 mmHg or \> 140/90 mmHg, or SpO2 less than 95%.

Outcomes

Primary Outcomes

Not specified

Similar Trials